Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation
- 4 January 2021
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 4 (1) , e2032053
Abstract
Tobacco remains the leading cause of preventable morbidity and mortality in the US, accounting for more than 480 000 total deaths and more than 34% of all cancer deaths annually.1 Although non-Hispanic Black individuals (referred to hereafter as Black) have a prevalence of smoking that is comparable to that of non-Hispanic White individuals (referred to hereafter as White), smoke fewer cigarettes per day (CPD), and smoke on fewer days of the month,2-5 they have higher rates of smoking-related morbidity and mortality.6-8Keywords
This publication has 83 references indexed in Scilit:
- Individual- and area-level unemployment influence smoking cessation among African Americans participating in a randomized clinical trialSocial Science & Medicine, 2012
- Bupropion for Smoking Cessation in African American Light Smokers: A Randomized Controlled TrialJNCI: Journal of the National Cancer Institute, 2012
- Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trialsNicotine & Tobacco Research, 2010
- Mechanisms linking socioeconomic status to smoking cessation: A structural equation modeling approach.Health Psychology, 2010
- Comparing smoking treatment programs for lighter smokers with and without a history of heavier smokingJournal of Substance Abuse Treatment, 2009
- Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United StatesJournal of Public Health, 2009
- Differential success rates in racial groups: Results of a clinical trial of smoking cessation among female prisonersNicotine & Tobacco Research, 2009
- A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivoThe Pharmacogenomics Journal, 2009
- Intermittent and light daily smoking across racial/ethnic groups in the United StatesNicotine & Tobacco Research, 2009
- A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descentPharmacogenetics and Genomics, 2008